Chapin Davis, Inc. Heart Test Laboratories, Inc. Transaction History

Chapin Davis, Inc.

  • $293 Billion
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 11, 2024
SELL
$0.15 - $0.43 $6,000 - $17,200
-40,000 Reduced 72.73%
15,000 $2.57 Million
Q4 2022

Jan 27, 2023
BUY
$0.8 - $267.0 $44,000 - $14.7 Million
55,000 New
55,000 $46.2 Million

About Heart Test Laboratories, Inc.

HSCS Quotes by TradingView
  • Ticker HSCS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 8,202,550
  • Market Cap $42.6M
  • Description
  • Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional 12-lead resting ECG information. It serves clinics, doctor's offices, urg...
More about HSCS
Track This Portfolio

Track Chapin Davis, Inc. Portfolio

Follow Chapin Davis, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chapin Davis, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Chapin Davis, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email